Key result
Drug therapy for mild hypertension benefits patients with DBP >100 mm Hg or preexisting CV disease.
Why the study?
The benefits of drug therapy for mild hypertension have been difficult to demonstrate, especially outside patients with diastolic blood pressure >100 mm Hg or preexisting cardiovascular abnormalities.
Key points are not available for this paper at this time.
Design
Other
May warrant individualized therapy for mild hypertension without high-risk features; leaves open benefit in low-risk groups.
The benefits of drug therapy for mild hypertension have been difficult to demonstrate. Evidence supports treatment of persons with diastolic blood pressures greater than 100 mm Hg and persons with preexisting cardiovascular abnormalities. However, drug therapy for others with mild hypertension should be individualized, and physicians should be aware of the expected benefits and limitations.
No takes yet. Share an insight, caveat, or question.
Robert L. Wilburn (1984) studied this question. Drug therapy for mild hypertension is supported in patients with diastolic blood pressure >100 mm Hg or preexisting cardiovascular abnormalities, but should be individualized for other patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: